Lower allopregnanolone during pregnancy predicts postpartum depression: An exploratory study

Multiple Imputation for Nonresponse in Surveys

Rubin, D. B. (1987) · Wiley Series in Probability and Statistics · doi:10.1002/9780470316696 · Cited by 20,701 · see citing works

Multiple Imputation for Nonresponse in Surveys.

Lynn, P. J., & Rubin, D. B. (1988) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348774 · Cited by 2,330 · see citing works

Effects of gonadal steroids in women with a history of postpartum depression

Bloch, M., Schmidt, P. J., Danaceau, M., Murphy, J., Nieman, L., & Rubinow, D. R. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.924 · Cited by 950 · see citing works

Biological and psychosocial predictors of postpartum depression: systematic review and call for integration

Yim, I. S., Tanner Stapleton, L. R., Guardino, C. M., Hahn-Holbrook, J., & Dunkel Schetter, C. (2015) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-101414-020426 · Cited by 749 · see citing works

Interactions between the Hypothalamic-Pituitary-Adrenal Axis and the Female Reproductive System: Clinical Implications

Chrousos, G. P., Torpy, D. J., & Gold, P. W. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-3-199808010-00012 · Cited by 707 · see citing works

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

Uzunova, V., Sheline, Y. I., Davis, J. M., Rasmusson, A. M., Uzunov, D. P., Costa, E., & Guidotti, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3239 · Cited by 672 · see citing works

Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II

Harris, B. L., Lovett, L. M., Newcombe, R. G., Read, G. F., Walker, R., & Riad-Fahmy, D. (1994) · BMJ · doi:10.1136/bmj.308.6934.949 · Cited by 487 · see citing works

The role of reproductive hormones in postpartum depression

Schiller, C. E., Meltzer-Brody, S. E., & Rubinow, D. R. (2014) · CNS Spectrums · doi:10.1017/s1092852914000480 · Cited by 480 · see citing works

Effects of Antidepressant Treatment on Neuroactive Steroids in Major Depression

Romeo, E., Ströhle, A., Spalletta, G., di Michele, F., Hermann, B., Holsboer, F., Pasini, A., & Rupprecht, R. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.910 · Cited by 463 · see citing works

GABAAR Plasticity during Pregnancy: Relevance to Postpartum Depression

Maguire, J., & Mody, I. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.019 · Cited by 437 · see citing works

Revisiting the roles of progesterone and allopregnanolone in the nervous system: Resurgence of the progesterone receptors

Schumacher, M., Mattern, C., Ghoumari, A. M., Oudinet, J., Lière, P., Labombarda, F., Sitruk-Ware, R. L., Nicola, A. F. D., & Guennoun, R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 353 · see citing works

The role of allopregnanolone in depression and anxiety

Schüle, C., Nothdurfter, C., & Rupprecht, R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.003 · Cited by 318 · see citing works

New insights into the role of perinatal HPA-axis dysregulation in postpartum depression

Glynn, L. M., Davis, E. P., & Sandman, C. A. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.007 · Cited by 268 · see citing works

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.

Girdler, S., Straneva, P. A., Light, K., Pedersen, C., & Morrow, A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01044-1 · Cited by 268 · see citing works

Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake

Pinna, G., Costa, E., & Guidotti, A. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0213-2 · Cited by 245 · see citing works

Allopregnanolone and mood disorders

Bäckström, T. C., Bixo, M., Johansson, M., Nyberg, S., Ossewaarde, L., Ragagnin, G., Savić, I., Strömberg, J., Timby, E., van Broekhoven, F., et al. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.07.005 · Cited by 212 · see citing works

Concentrations of 3α-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery

Ströhle, A., Romeo, E., Hermann, B., Pasini, A., Spalletta, G., di Michele, F., Holsboer, F., & Rupprecht, R. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00328-x · Cited by 194 · see citing works

Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women

Yonkers, K. A., Vigod, S. N., & Ross, L. E. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31821187a7 · Cited by 183 · see citing works

HORMONAL ASPECTS OF POSTPARTUM DEPRESSION

Abou‐Saleh, M. T. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00022-5 · Cited by 168 · see citing works

Serum allopregnanolone in women with postpartum “blues”

Nappi, R. (2001) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(00)01112-1 · Cited by 166 · see citing works

Estrogen-related Mood Disorders

Douma, S. L., Husband, C., OʼDonnell, M. E., Barwin, B. N., & Woodend, A. (2005) · Advances in Nursing Science · doi:10.1097/00012272-200510000-00008 · Cited by 164 · see citing works

Plasma Concentrations of Neuroactive Steroids before and after Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression

Padberg, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00355-x · Cited by 155 · see citing works

GABAergic neuroactive steroids and resting-state functional connectivity in postpartum depression: A preliminary study

Deligiannidis, K. M., Şıkoğlu, E. M., Shaffer, S. A., Frederick, B. B., Svenson, A., Kopoyan, A., Kosma, C. A., Rothschild, A. J., & Moore, C. M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.02.010 · Cited by 153 · see citing works

Preliminary evidence of reduced occipital GABA concentrations in puerperal women: a 1H-MRS study

Epperson, C. N., Gueorguieva, R. V., Czarkowski, K. A., Stiklus, S. M., Sellers, E. M., Krystal, J. H., Rothman, D. L., & Mason, G. F. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0313-7 · Cited by 145 · see citing works

A Reproductive Subtype of Depression

Payne, J. L., Palmer, J. T., & Joffe, H. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902899706 · Cited by 144 · see citing works

Low Serum Allopregnanolone Is Associated with Symptoms of Depression in Late Pregnancy

Hellgren, C., Åkerud, H., Skalkidou, A., Bäckström, T. C., & Poromaa, I. S. (2014) · Neuropsychobiology · doi:10.1159/000358838 · Cited by 137 · see citing works

Pregnancy-Associated Death: A Qualitative Systematic Review of Homicide and Suicide

Shadigian, E. M., & Bauer, S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000155967.72418.6b · Cited by 126 · see citing works

GABA receptors, progesterone and premenstrual dysphoric disorder

Poromaa, I., Smith, S., & Gulinello, M. (2003) · Archives of Women's Mental Health · doi:10.1007/s00737-002-0147-1 · Cited by 123 · see citing works

GABAA Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment

Ströhle, A., Romeo, E., di Michele, F., Pasini, A., Yassouridis, A., Holsboer, F., & Rupprecht, R. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.145 · Cited by 120 · see citing works

3α-reduced neuroactive steroids and their precursors during pregnancy and the postpartum period

Evans, S. E. G., Ross, L. E., Sellers, E. M., Purdy, R. H., & Romach, M. K. (2005) · Gynecological Endocrinology · doi:10.1080/09513590500361747 · Cited by 114 · see citing works

Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression

Deligiannidis, K. M., Kroll‐Desrosiers, A., Mo, S., Nguyen, H. P., Svenson, A., Jaitly, N., Hall, J. E., BARTON, B. A., Rothschild, A. J., & Shaffer, S. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.05.010 · Cited by 114 · see citing works

Relevance of endogenous 3α-reduced neurosteroids to depression and antidepressant action

Uzunova, V., Sampson, L., & Uzunov, D. P. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0201-6 · Cited by 108 · see citing works

Allopregnanolone as a mediator of affective switching in reproductive mood disorders

Schiller, C. E., Schmidt, P. J., & Rubinow, D. R. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3599-x · Cited by 107 · see citing works

Cardiff Puerperal Mood and Hormone Study. III. Postnatal Depression at 5 to 6 Weeks Postpartum, and its Hormonal Correlates Across the Peripartum Period

Harris, B., Lovett, L. M., Smith, J., Read, G., Walker, R., & Newcombe, R. G. (1996) · The British Journal of Psychiatry · doi:10.1192/bjp.168.6.739 · Cited by 105 · see citing works

Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels

Osborne, L. M., Clive, M. L., Kimmel, M., Gispen, F. E., Guintivano, J., Brown, T., Cox, O., Judy, J., Meilman, S., Braier, A., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.333 · Cited by 103 · see citing works

Transdermal Estradiol for Postpartum Depression: A Promising Treatment Option

Moses‐Kolko, E. L., Berga, S. L., Kalro, B. N., Sit, D. K. Y., & Wisner, K. L. (2009) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0b013e3181b5a395 · Cited by 97 · see citing works

Fluoxetine decreases concentrations of 3α,5α-tetrahydrodeoxycorticosterone (THDOC) in major depression

Ströhle, A., Pasini, A., Romeo, E., Hermann, B., Spalletta, G., di Michele, F., Holsboer, F., & Rupprecht, R. (2000) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(00)00006-6 · Cited by 88 · see citing works

Multifunctional aspects of allopregnanolone in stress and related disorders

Bali, A., & Jaggi, A. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.005 · Cited by 87 · see citing works

The role of estrogen and progesterone in depression after birth

Klier, C. M., Muzik, M., Dervic, K., Mossaheb, N., Benesch, T., Ulm, B., & Zeller, M. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.09.002 · Cited by 83 · see citing works

Neuroactive Ring A-Reduced Metabolites of Progesterone in Human Plasma during Pregnancy: Elevated Levels of 5α-Dihydroprogesterone in Depressed Patients during the Latter Half of Pregnancy

Murphy, B. E. P., Steinberg, S. I., Hu, F.-Y., & Allison, C. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8122 · Cited by 74 · see citing works

Postpartum blues: Relationship between not-protein bound steroid hormones in plasma and postpartum mood changes

Heidrich, A., Schleyer, M., Spingler, H., Albert, P. J., Knoche, M., Fritze, J., & Lanczik, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90036-1 · Cited by 71 · see citing works

A history of depression in women is associated with an altered GABAergic neuroactive steroid profile

Girdler, S. S., Lindgren, M., Porcu, P., Rubinow, D. R., Johnson, J. L., & Morrow, A. L. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.08.004 · Cited by 66 · see citing works

Response to Flumazenil in Women With Premenstrual Dysphoric Disorder

Mellédo, J. L., Driel, M. V., Coupland, N. J., Lott, P., & Jhangri, G. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.821 · Cited by 64 · see citing works

Blunted neuroactive steroid and HPA axis responses to stress are associated with reduced sleep quality and negative affect in pregnancy: a pilot study

Crowley, S. K., O’Buckley, T. K., Schiller, C. E., Stuebe, A. M., Morrow, A. L., & Girdler, S. S. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4217-x · Cited by 64 · see citing works

Histories of depression, allopregnanolone responses to stress, and premenstrual symptoms in women

Klatzkin, R. R., Morrow, A. L., Light, K. C., Pedersen, C. A., & Girdler, S. S. (2005) · Biological Psychology · doi:10.1016/j.biopsycho.2005.02.007 · Cited by 63 · see citing works

Neuroactive steroids as modulators of depression and anxiety

Eser, D., Romeo, E., Baghai, T. C., di Michele, F., Schüle, C., Pasini, A., Zwanzger, P., Padberg, F., & Rupprecht, R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.007 · Cited by 54 · see citing works

PLASMA AMINE AND HORMONE CHANGES IN ‘POST‐PARTUM BLUEs'

KUEVI, V., Causon, R. C., Dixson, A. F., Everard, D. M., HALL, J. M., Hole, D. R., Whitehead, S. A., WILSON, C. A., & Wise, J. C. M. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb00740.x · Cited by 54 · see citing works

‘Maternity blues’ and hormone levels in saliva

FEKSI, A., HARRIS, B., WALKER, R., Riad-Fahmy, D., & Newcombe, R. G. (1984) · Journal of Affective Disorders · doi:10.1016/s0165-0327(84)80013-0 · Cited by 53 · see citing works

Role of progesterone and other neuroactive steroids in anxiety disorders

Melledo, J. L., & Baker, G. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.5.851 · Cited by 46 · see citing works

Family history, not lack of medication use, is associated with the development of postpartum depression in a high-risk sample

Kimmel, M., Hess, E., Roy, P. S., Palmer, J. T., Meltzer-Brody, S. E., Meuchel, J. M., Bost-Baxter, E., & Payne, J. L. (2014) · Archives of Women s Mental Health · doi:10.1007/s00737-014-0432-9 · Cited by 38 · see citing works

Plasticity and function of extrasynaptic GABAA receptors during pregnancy and after delivery

Mostallino, M. C., Sanna, E., Concas, A., Biggio, G., & Follesa, P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.013 · Cited by 32 · see citing works

Progesterone and its metabolites as therapeutic targets in psychiatric disorders

Bristot, G., Ascoli, B. M., Gubert, C., Panizzutti, B., Kapczinski, F. P., & Rosa, A. R. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.897329 · Cited by 29 · see citing works

Reproductive hormones and postpartum mood disturbances in Greek women

Chatzicharalampous, C., Rizos, D., Pliatsika, P., Leonardou, A. A., Hassiakos, D., Zervas, I. M., Alexandrou, A., Creatsa, M. G., Konidaris, S., & Lambrinoudaki, I. V. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.501886 · Cited by 28 · see citing works

Diurnal variation in saliva estriol level during pregnancy: A pilot study

McGregor, J., Hastings, C., Roberts, T. J., & Barrett, J. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70705-2 · Cited by 20 · see citing works

Chapter 6 GABAA Receptor Function and Gene Expression During Pregnancy and Postpartum

Biggio, G., Mostallino, M. C., Follesa, P., Concas, A., & Sanna, E. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)85006-x · Cited by 18 · see citing works

Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials.

Meltzer-Brody, S., Colquhoun, H., Riesenberg, R., Epperson, C. N., Deligiannidis, K. M., Rubinow, D. R., Li, H., Sankoh, A. J., Clemson, C., Schacterle, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31551-4 · Cited by 795 · see citing works

Pathophysiological mechanisms implicated in postpartum depression

Payne, J. L., & Maguire, J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2018.12.001 · Cited by 459 · see citing works

Predictors of Postpartum Depression: A Comprehensive Review of the Last Decade of Evidence

Guintivano, J., Manuck, T. A., & Meltzer-Brody, S. E. (2018) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000368 · Cited by 338 · see citing works

Effect of Zuranolone vs Placebo in Postpartum Depression

Deligiannidis, K. M., Meltzer-Brody, S., Gunduz-Bruce, H., Doherty, J., Jonas, J., Li, S., Sankoh, A. J., Silber, C., Campbell, A. D., Werneburg, B., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.1559 · Cited by 277 · see citing works

Brexanolone for postpartum depression: A meta-analysis of randomized controlled studies

Zheng, W., Cai, D.-B., Zheng, W., Sim, K., Ungvari, G. S., Peng, X.-J., Ning, Y., Wang, G., & Xiang, Y. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.07.006 · Cited by 219 · see citing works

Allopregnanolone in premenstrual dysphoric disorder (PMDD): Evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle

Hantsoo, L., & Epperson, C. N. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100213 · Cited by 199 · see citing works

Progesterone – Friend or foe?

Poromaa, I. S., Comasco, E., Sumner, R. L., & Eileen Luders, A. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100856 · Cited by 199 · see citing works

Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development

Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156 · see citing works

Recent advances in understanding/management of premenstrual dysphoric disorder/premenstrual syndrome

Tiranini, L., & Nappi, R. E. (2022) · Faculty Reviews · doi:10.12703/r/11-11 · Cited by 138 · see citing works

Neuroactive Steroids and GABAergic Involvement in the Neuroendocrine Dysfunction Associated With Major Depressive Disorder and Postpartum Depression

Maguire, J. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00083 · Cited by 113 · see citing works

Progesterone Actions During Central Nervous System Development

González-Orozco, J. C., & Camacho‐Arroyo, I. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00503 · Cited by 104 · see citing works

Allopregnanolone: An overview on its synthesis and effects

Diviccaro, S., Cioffi, L., Falvo, E., Giatti, S., & Melcangi, R. C. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.12996 · Cited by 110 · see citing works

Allopregnanolone-based treatments for postpartum depression: Why/how do they work?

Walton, N., & Maguire, J. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100198 · Cited by 103 · see citing works

Sex differences in the hypothalamic–pituitary–adrenal axis: An obstacle to antidepressant drug development?

Kokras, N., Hodes, G. E., Bangasser, D. A., & Dalla, C. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14710 · Cited by 94 · see citing works

Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review

Edinoff, A. N., Odisho, A. S., Lewis, K., Kaskas, A. M., Hunt, G., Cornett, E. M., Kaye, A. D., Kaye, A. M., Morgan, J. H., Barrilleaux, P. S., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.699740 · Cited by 95 · see citing works

Postpartum Depression: Current Status and Possible Identification Using Biomarkers

Yu, Y., Liang, H.-F., Chen, J., Li, Z., Han, Y., Chen, J.-X., & Li, J.-C. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.620371 · Cited by 91 · see citing works

Innate immune activation and depressive and anxious symptoms across the peripartum: An exploratory study

Osborne, L. M., Yenokyan, G., Fei, K., Kraus, T., Moran, T. M., Monk, C. E., & SPERLING, R. S. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.08.038 · Cited by 83 · see citing works

Novel antidepressant drugs: Beyond monoamine targets

Gonda, X., Döme, P., Neill, J. C., & Tarazi, F. I. (2021) · CNS Spectrums · doi:10.1017/s1092852921000791 · Cited by 81 · see citing works

Towards understanding the biology of premenstrual dysphoric disorder: From genes to GABA

Hantsoo, L. V., & Payne, J. L. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105168 · Cited by 72 · see citing works

Neural correlates of depression in women across the reproductive lifespan – An fMRI review

Stickel, S., Wagels, L., Wudarczyk, O. A., Jaffee, S. R., Habel, U., Schneider, F. W., & Chechko, N. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.12.133 · Cited by 70 · see citing works

Allopregnanolone in mood disorders: Mechanism and therapeutic development

Chen, S., Gao, L., Li, X., & Ye, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105682 · Cited by 69 · see citing works

Realising the therapeutic potential of neuroactive steroid modulators of the GABAA receptor

Belelli, D., Hogenkamp, D., Gee, K. W., & Lambert, J. J. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100207 · Cited by 67 · see citing works

The Menstrual Cycle Influences Emotion but Has Limited Effect on Cognitive Function.

Sundström-Poromaa, I. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.01.016 · Cited by 62 · see citing works

Animal models of post-traumatic stress disorder and novel treatment targets

Aspesi, D., & Pinna, G. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000467 · Cited by 65 · see citing works

Brexanolone therapeutics in post-partum depression involves inhibition of systemic inflammatory pathways

Balan, I. S., Patterson, R., Boero, G., Krohn, H., O’Buckley, T. K., Meltzer-Brody, S. E., & Morrow, A. L. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104473 · Cited by 64 · see citing works

Stigmasterol can be new steroidal drug for neurological disorders: Evidence of the GABAergic mechanism via receptor modulation

Karim, N., Khan, I., Abdelhalim, A., Halim, S. A., Khan, A., & Al-Harrasi, A. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153646 · Cited by 63 · see citing works

A Comprehensive Review on Postpartum Depression

Suryawanshi, O., & Pajai, S. (2022) · Cureus · doi:10.7759/cureus.32745 · Cited by 63 · see citing works

Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease

Deems, N. P., & Leuner, B. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100820 · Cited by 63 · see citing works

Neurosteroids and Neurotrophic Factors: What Is Their Promise as Biomarkers for Major Depression and PTSD?

Almeida, F. B., Barros, H. M. T., & Pinna, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041758 · Cited by 57 · see citing works

Factors Related to Seeking Help for Postpartum Depression: A Secondary Analysis of New York City PRAMS Data

Córdoba, S. M., Pickering, S., Ortega, M. A., Asúnsolo, Á., & Romero, D. R. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17249328 · Cited by 55 · see citing works

Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway

Hellgren, C., Comasco, E., Skalkidou, A., & Poromaa, I. S. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.06.008 · Cited by 55 · see citing works

Tau Phosphorylation in Female Neurodegeneration: Role of Estrogens, Progesterone, and Prolactin

Muñoz-Mayorga, D., Guerra‐Araiza, C., Torner, L., & Morales, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00133 · Cited by 55 · see citing works

Allopregnanolone and reproductive psychiatry: an overview

McEvoy, K., & Osborne, L. M. (2019) · International Review of Psychiatry · doi:10.1080/09540261.2018.1553775 · Cited by 51 · see citing works

Leveraging research into sex differences and steroid hormones to improve brain health

Lee, B. H., Eid, R. S., Hodges, T. E., Barth, C., & Galea, L. A. M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01061-0 · Cited by 48 · see citing works

The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms

Osborne, L. M., Betz, J., Yenokyan, G., Standeven, L. R., & Payne, J. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01033 · Cited by 46 · see citing works

Multi-omics and machine learning for the prevention and management of female reproductive health

Kharb, S., & Joshi, A. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1081667 · Cited by 47 · see citing works

Progesterone and Its Metabolites Play a Beneficial Role in Affect Regulation in the Female Brain

Stefaniak, M., Dmoch–Gajzlerska, E., Jankowska, K. K., Rogowski, A., Kajdy, A., & Maksym, R. (2023) · Pharmaceuticals · doi:10.3390/ph16040520 · Cited by 45 · see citing works

T-cell defects and postpartum depression

Osborne, L. M., Gilden, J., Kamperman, A. M., Hoogendijk, W. J. G., Spicer, J., Drexhage, H. A., & Bergink, V. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.007 · Cited by 45 · see citing works

Progesterone, reproduction, and psychiatric illness

Standeven, L. R., McEvoy, K., & Osborne, L. M. (2020) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2020.06.001 · Cited by 52 · see citing works

Transmission of the adverse consequences of childhood maltreatment across generations: Focus on gestational biology

Moog, N. K., Heim, C. C., Entringer, S., Simhan, H. N., Wadhwa, P. D., & Buß, C. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173372 · Cited by 43 · see citing works

Allopregnanolone in Postpartum Depression

Pinna, G., Almeida, F. B., & Davis, J. M. (2022) · Frontiers in Global Women s Health · doi:10.3389/fgwh.2022.823616 · Cited by 42 · see citing works

Maternal Distress and Offspring Neurodevelopment: Challenges and Opportunities for Pre-clinical Research Models

Fitzgerald, E., Parent, C. I., Kee, M. Z. L., & Meaney, M. J. (2021) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2021.635304 · Cited by 39 · see citing works

Management of perinatal depression with non-drug interventions

Johansen, S. L., Robakis, T. K., Williams, K. E., & Rasgon, N. (2019) · BMJ · doi:10.1136/bmj.l322 · Cited by 40 · see citing works

The plasma metabolome of women in early pregnancy differs from that of non-pregnant women

Handelman, S. K., Romero, R. J., Tarca, A. L., Pacora, P., Ingram, B. O., Maymon, E., Chaiworapongsa, T., Hassan, S. S., & Erez, O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224682 · Cited by 38 · see citing works

Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy

Reddy, D. S., Mbilinyi, R. H., & Estes, E. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06427-2 · Cited by 37 · see citing works

Perinatal depression: Heterogeneity of disease and in animal models

Qiu, W., Hodges, T. E., Clark, E. L., Blankers, S. A., & Galea, L. A. M. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100854 · Cited by 37 · see citing works

Neuroactive steroids and depression in early pregnancy

Wenzel, E., Pinna, G., Eisenlohr-Moul, T. A., Bernabé, B. P., Romay-Tallón, R., Nagelli, U., Davis, J. M., & Maki, P. M. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105424 · Cited by 37 · see citing works

Gut microbiota: Linking nutrition and perinatal depression

Song, J. G., Bi, Z., Kan, J., Liu, G., Zhang, S., Si, L., Zhang, X., Yang, X., Ma, J., Cheng, J., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.932309 · Cited by 37 · see citing works

Exposure to environmental chemicals and perinatal psychopathology

Jacobson, M. H., Ghassabian, A., Gore, A. C., & Trasande, L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114835 · Cited by 36 · see citing works

Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review

Marecki, R., Kałuska, J., Kolanek, A., Hakało, D., & Waszkiewicz, N. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1298359 · Cited by 35 · see citing works

Neuroactive Steroids and Perinatal Depression: a Review of Recent Literature

McEvoy, K., Payne, J. L., & Osborne, L. M. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0937-4 · Cited by 35 · see citing works

Risk of Depression Associated With Finasteride Treatment

Pompili, M., Magistri, C., Maddalena, S., Mellini, C., Persechino, S., & Baldessarini, R. J. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001379 · Cited by 34 · see citing works

Metabolic Profiling Indicates Diversity in the Metabolic Physiologies Associated With Maternal Postpartum Depressive Symptoms

Bränn, E., Malavaki, C. J., Fransson, E., Ioannidi, M.-K., Henriksson, H. E., Papadopoulos, F. C., Chrousos, G. P., Klapa, M. I., & Skalkidou, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.685656 · Cited by 32 · see citing works

Baby blues, premenstrual syndrome and postpartum affective disorders: intersection of risk factors and reciprocal influences

Chechko, N., Losse, E. M., Frodl, T., & Nehls, S. (2023) · BJPsych Open · doi:10.1192/bjo.2023.612 · Cited by 32 · see citing works

Prenatal Exposure to Bisphenols and Phthalates and Postpartum Depression: The Role of Neurosteroid Hormone Disruption

Jacobson, M. H., Stein, C. R., Liu, M., Ackerman, M. G., Blakemore, J. K., Long, S. E., Pinna, G., Romay-Tallón, R., Kannan, K., Zhu, H., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab199 · Cited by 33 · see citing works

Relating neurosteroid modulation of inhibitory neurotransmission to behaviour

Belelli, D., Phillips, G., Atack, J. R., & Lambert, J. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13045 · Cited by 32 · see citing works

Longitudinal proneuroactive and neuroactive steroid profiles in medication-free women with, without and at-risk for perinatal depression: a liquid chromatography-tandem mass spectrometry analysis.

Deligiannidis, K. M., Kroll-Desrosiers, A. R., Tan, Y., Dubuke, M. L., & Shaffer, S. A. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104827 · Cited by 31 · see citing works

The role of inflammation in the pathogenesis of perinatal depression and offspring outcomes

Sawyer, K. M. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100390 · Cited by 32 · see citing works

Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites

Giatti, S., Diviccaro, S., Falvo, E., García‐Segura, L. M., & Melcangi, R. C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100836 · Cited by 32 · see citing works

Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?

Faden, J., & Citrome, L. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320968658 · Cited by 30 · see citing works

Potential therapeutic effects of Chinese herbal medicine in postpartum depression: Mechanisms and future directions

Xie, H., Xie, Z., Luan, F., Zeng, J., Zhang, X., Chen, L., Zeng, N., & Liu, R. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117785 · Cited by 27 · see citing works

Neurobiology of maternal mental illness

Maguire, J., McCormack, C., Mitchell, A., & Monk, C. E. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64239-4.00005-9 · Cited by 27 · see citing works

Do dehydroepiandrosterone, progesterone, and testosterone influence women’s depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women

Walther, A., Tsao, C., Pande, R., Kirschbaum, C., Field, E., & Berkman, L. F. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104382 · Cited by 27 · see citing works

The placental programming hypothesis: Placental endocrine insufficiency and the co-occurrence of low birth weight and maternal mood disorders

Creeth, H., & John, R. M. (2020) · Placenta · doi:10.1016/j.placenta.2020.03.011 · Cited by 26 · see citing works

Becoming a Mother During COVID-19 Pandemic: How to Protect Maternal Mental Health Against Stress Factors

Bottemanne, H., Vahdat, B., Jouault, C., Tibi, R., & Joly, L. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.764207 · Cited by 26 · see citing works

Clostridium innocuum , an opportunistic gut pathogen, inactivates host gut progesterone and arrests ovarian follicular development

Chen, M., Chou, C., Hsiao, T., Wu, T.-Y., Li, C., Chen, Y., Chao, K., Lee, T., Gicana, R. G., Shih, C.-J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2424911 · Cited by 24 · see citing works

Anxiolytic and Anti-depressive Like Effects of Translocator Protein (18 kDa) Ligand YL-IPA08 in a Rat Model of Postpartum Depression

Ren, P., Ma, L., Wang, J.-Y., Guo, H., Sun, L. J., Gao, M., Liu, Y., Ma, Y., Li, Y., & Guo, W.-Z. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03036-9 · Cited by 23 · see citing works

Brexanolone for the treatment of patients with postpartum depression

Morrison, K. E., Cole, A. B., Thompson, S. M., & Bale, T. L. (2019) · Drugs of today · doi:10.1358/dot.2019.55.9.3040864 · Cited by 22 · see citing works

Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study

Standeven, L. R., Osborne, L. M., Betz, J., Yenokyan, G., Voegtline, K., Hantsoo, L. V., & Payne, J. L. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01186-5 · Cited by 21 · see citing works

Effects of fast-acting antidepressant drugs on a postpartum depression mice model

García-Baos, A., Gallego‐Landin, I., Ferreres-Álvarez, I., Puig-Reyné, X., Castro‐Zavala, A., Valverde, O., & Martín‐Sánchez, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113598 · Cited by 19 · see citing works

Role of allopregnanolone-mediated γ-aminobutyric acid A receptor sensitivity in the pathogenesis of premenstrual dysphoric disorder: Toward precise targets for translational medicine and drug development

Gao, Q., Sun, W., Wang, Y.-R., Li, Z., Zhao, F., Geng, X., Xu, K., Chen, D., Liu, K., Xing, Y., et al. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1140796 · Cited by 23 · see citing works

Pilot validation of blood-based biomarkers during pregnancy and postpartum in women with prior or current depression

Redei, E. E., Ciolino, J. D., Wert, S. L., Yang, A., Kim, S., Clark, C. T., Zumpf, K. B., & Wisner, K. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01188-4 · Cited by 20 · see citing works

The relationship of potential biomarkers with psychological resilience and post-traumatic growth in female patients with breast cancer

Gündoğmuş, A. G., Katar, K. S., Örsel, S., Öztürk, G., & Yılmaz, K. B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277119 · Cited by 19 · see citing works

Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression

Carlini, S. V., Osborne, L. M., & Deligiannidis, K. M. (2023) · Dialogues in Clinical Neuroscience · doi:10.1080/19585969.2023.2262464 · Cited by 20 · see citing works

GABAA dysregulation as an explanatory model for late-onset postpartum depression associated with weaning and resumption of menstruation

Burke, C. S., Susser, L. C., & Hermann, A. D. (2018) · Archives of Women s Mental Health · doi:10.1007/s00737-018-0871-9 · Cited by 19 · see citing works

Evolutionary and genetic insights for clinical psychology

Crespi, B. J. (2020) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101857 · Cited by 18 · see citing works

The neurobiology of postpartum depression

Wenzel, E., Frye, R., Roberson‐Nay, R., & Payne, J. L. (2025) · Trends in Neurosciences · doi:10.1016/j.tins.2025.05.005 · Cited by 18 · see citing works

Neurosteroids: A potential target for neuropsychiatric disorders

Wang, M., Hu, S.-W., Fu, X., Zhou, H., Yang, S., & Yang, C. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106485 · Cited by 18 · see citing works

Women’s Psychiatry

Balta, G., Dalla, C., & Kokras, N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_11 · Cited by 18 · see citing works

Metabolites of progesterone in pregnancy: Associations with perinatal anxiety

Etyemez, S., Miller, K. N., Voegtline, K., Özdemir, İ., Standeven, L. R., Santovito, L. S., Pinna, G., Payne, J. L., & Osborne, L. M. (2023) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2023.106327 · Cited by 17 · see citing works

Progesterone distribution in the trigeminal system and its role to modulate sensory neurotransmission: influence of sex

Maddahi, A., Warfvinge, K., Holm, A., Edvinsson, J. C. A., Reducha, P. V., Kazantzi, S., Haanes, K. A., & Edvinsson, L. I. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01687-x · Cited by 17 · see citing works

Conventional and new immunotherapies for immune system dysregulation in postpartum mood disorders: comparisons to immune system dysregulations in bipolar disorder, major depression, and postpartum autoimmune thyroid disease

Drexhage, H. A., Bergink, V., Poletti, S., Benedetti, F., & Osborne, L. M. (2024) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2024.2420053 · Cited by 16 · see citing works

Progestogen profiling in plasma during the estrous cycle in cattle using an LC-MS based approach

Hankele, A., Rehm, K., Bérard, J., Schuler, G. C., Bigler, L., & Ulbrich, S. E. (2019) · Theriogenology · doi:10.1016/j.theriogenology.2019.10.005 · Cited by 16 · see citing works

What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies

Dabbah‐Assadi, F., Handel, R., & Shamir, A. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.032 · Cited by 14 · see citing works

Examining the relationship between mothers' prenatal mental health and demographic factors with postpartum depression

Kazemi, A., Ghaedrahmati, M., Kheirabadi, G., Bahrami, M., & Ebrahimi, A. (2018) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_6_18 · Cited by 14 · see citing works

A multilevel developmental psychopathology model of childbirth and the perinatal transition

Kaliush, P. R., Conradt, E. D., Kerig, P. K., Williams, P., & Crowell, S. E. (2023) · Development and Psychopathology · doi:10.1017/s0954579422001389 · Cited by 13 · see citing works

Progesterone modulates theta oscillations in the frontal‐parietal network

Riddle, J., Ahn, S., McPherson, T., Girdler, S. S., & Frӧhlich, F. (2020) · Psychophysiology · doi:10.1111/psyp.13632 · Cited by 13 · see citing works

Neuroactive steroid exposure impacts neurodevelopment: Comparison of human and rodent placental contribution

Vacher, C., Tsompanidis, A., Firestein, M. R., & Penn, A. A. (2025) · Journal of Neuroendocrinology · doi:10.1111/jne.13489 · Cited by 12 · see citing works

Migraine as a risk factor for mixed symptoms of peripartum depression and anxiety in late pregnancy: A prospective cohort study

Welander, N. Z., Mwinyi, J., Asif, S., Schiöth, H. B., Skalkidou, A., & Fransson, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.119 · Cited by 12 · see citing works

Biomarkers and treatments for mood disorders encompassing the neurosteroid and endocannabinoid systems

Pinna, G. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13226 · Cited by 12 · see citing works

Postpartum depression and mother–offspring conflict over maternal investment

Gunst, A., Sundén, M., Korja, R., Boddy, A. M., Kotler, J., Paavonen, E. J., Uusitupa, H., Karlsson, L., Karlsson, H., & Antfolk, J. (2020) · Evolution Medicine and Public Health · doi:10.1093/emph/eoaa049 · Cited by 12 · see citing works

Neuroactive steroid biosynthesis during pregnancy predicts future postpartum depression: a role for the 3α and/or 3β-HSD neurosteroidogenic enzymes?

Osborne, L. M., Etyemez, S., Pinna, G., Alemani, R., Standeven, L. R., Wang, X., & Payne, J. L. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02052-z · Cited by 11 · see citing works

Neurosteroids and early-life programming: An updated perspective

Sze, Y., & Brunton, P. J. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100367 · Cited by 11 · see citing works

A review on menstrual health in adolescent girls emphasizing multi-omics and machine learning strategies for preventing reproductive tract infections

Ganguly, M., Ganguly, A., Chattaraj, S., & Midya, D. K. (2025) · Discover Public Health · doi:10.1186/s12982-025-00485-x · Cited by 14 · see citing works

Approche GABAergique de la dépression du post-partum : une revue critique translationnelle

Verbe, J., Dubertret, C., El‐Hage, W., Bonnet‐Brilhault, F., & Duriez, P. (2019) · L Encéphale · doi:10.1016/j.encep.2019.09.007 · Cited by 10 · see citing works

Development and validation of an LC-MS/MS assay for the quantification of allopregnanolone and its progesterone-derived isomers, precursors, and cortisol/cortisone in pregnancy

Mayne, G., Bloois, E. D., Dabelea, D., & Christians, U. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03523-0 · Cited by 10 · see citing works

Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes

Horwitz, A. B., & Rubín, R. T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1139889 · Cited by 10 · see citing works

The efficacy and safety of Zuranolone for treatment of depression: A systematic review and meta-analysis

Fayoud, A. M., Orebi, H. A., Elshnoudy, I. A., Elsebaie, M. A. T., Elewidi, M. M. M., & Sabra, H. K. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06611-y · Cited by 9 · see citing works

Biomarkers of reproductive psychiatric disorders

Etyemez, S., Mehta, K., Iyer, S., Özdemir, İ., & Osborne, L. M. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2025.134 · Cited by 8 · see citing works

Mid-pregnancy allopregnanolone levels and trajectories of perinatal depressive symptoms

Björvang, R. D., Walldén, Y., Fransson, E., Comasco, E., Poromaa, I. S., & Skalkidou, A. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107009 · Cited by 8 · see citing works

Allopregnanolone and depression and anxiety symptoms across the peripartum: an exploratory study

Standeven, L. R., Osborne, L. M., Betz, J., Yenokyan, G., Voegtline, K., Hantsoo, L. V., & Payne, J. L. (2021) · Archives of Women s Mental Health · doi:10.1007/s00737-021-01186-5 · Cited by 21 · see citing works

The Role of Allopregnanolone in Pregnancy in Predicting Postpartum Anxiety Symptoms

Osborne, L. M., Betz, J., Yenokyan, G., Standeven, L. R., & Payne, J. L. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01033 · Cited by 46 · see citing works

37. The Role of Allopregnanolone in Perinatal Mood and Anxiety Disorders

Osborne, L. M., Yenokyan, G., Sanyal, A., & Payne, J. L. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.03.051 · Cited by 1 · see citing works

Peripartum allopregnanolone blood concentrations and depressive symptoms: a systematic review and individual participant data meta-analysis.

Schoretsanitis, G., Osborne, L. M., Poromaa, I. S., Wenzel, E. S., Payne, J. L., Barbui, C., Gastaldon, C., & Deligiannidis, K. M. (2025) · Open Access CRIS of the University of Bern · doi:10.48620/78524

Levels of neuroactive steroids are elevated in those who develop first-onset depression early in pregnancy

Wenzel, E., Barone, J., Eisenlohr-Moul, T. A., Alvernaz, S. A., Bernabé, B. P., Santovito, L. S., Gdyana, I. M. M., Pinna, G., & Maki, P. M. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1557560 · Cited by 2 · see citing works